J9185 HCPCS Level II code: Injection, fludarabine phosphate, 50 mg
J9185 is the HCPCS code for “Injection, fludarabine phosphate, 50 mg” in CMS’s October 2026 release, in effect from Oct 1, 2026.
Official description
J9185Injection, fludarabine phosphate, 50 mg
Short description: Fludarabine phosphate inj
HCPCS · United States
Medicare details
The indicators CMS publishes with J9185 in its October 2026 file. They describe Medicare’s handling, not another payer’s.
- Medicare coverage
- Special coverage instructions apply
- Medicare pricing
- Drugs
- ASC
- Approved for ambulatory surgical centers
- Type of service
- Medical care; Lump sum purchase of DME, prosthetics, orthotics
- BETOS category
- Chemotherapy
- Added
- Jan 1, 1994
Where J9185 sits
- 1J codesDrugs administered other than orally
- 2Active code J9185Injection, fludarabine phosphate, 50 mg
Source and release
- Data release
- HCPCS Level II · October 2026
- Effective date
- Oct 1, 2026
- Publisher
- CMS
This page is built from the HCPCS Level II catalog that Vero Codes reads when it suggests codes: Centers for Medicare & Medicaid Services’s October 2026 release, imported from the publisher’s file and checked against it. The description, notes and structured data come from the same record.
Frequently asked questions
What does HCPCS code J9185 mean?
J9185 is the HCPCS code for “Injection, fludarabine phosphate, 50 mg” in CMS’s HCPCS Level II October 2026 release.
Does Medicare cover J9185?
CMS lists J9185’s Medicare coverage as “Special coverage instructions apply” and its pricing as “Drugs”. Coverage and payment still depend on the patient, the setting, the documentation and the payer.
Which HCPCS Level II release does this page use?
It uses CMS’s October 2026 release, in effect from Oct 1, 2026 to Dec 31, 2026. It is a reference: confirm the code against the current list and the payer’s rules before you submit it.
Codes beside J9185
All J codesJ9177Injection, enfortumab vedotin-ejfv, 0.25 mgJ9178Injection, epirubicin hcl, 2 mgJ9179Injection, eribulin mesylate, 0.1 mgJ9181Injection, etoposide, 10 mgJ9183Gemcitabine intravesical system, 225 mgJ9184Injection, gemcitabine hydrochloride (avyxa), 200 mgJ9186Injection, etoposide (avyxa), 1 mgJ9187Injection, etoposide, 1 mgJ9190Injection, fluorouracil, 500 mgJ9191Injection, fluorouracil (avyxa), 10 mgJ9192Injection, fluorouracil, 10 mgJ9196Injection, gemcitabine hydrochloride (accord), not therapeutically equivalent to j9201, 200 mg